Jamjoom Pharmaceuticals Factory Company: Business Overview, Financials & Competitive Analysis
Jamjoom Pharmaceuticals Factory Company scores 7/10 on the AskCyborg Cyborg Score (Strong). A diversified regional pharmaceutical manufacturer with strong revenue growth, solid profitability, and attractive dividend yield positioned in a resilient healthcare sector. The company demonstrated strong growth in 2024 with revenue increasing 19.77% to 1.32 billion SAR and earnings rising 21.93% to 356.52 million SAR. Dividend yield of 2.01%.
What is Jamjoom Pharmaceuticals Factory Company's industry? Jamjoom Pharmaceuticals Factory Company (jamjoompharma.com) operates in Pharmaceuticals & Consumer Healthcare. AskCyborg classifies Jamjoom Pharmaceuticals Factory Company under Pharmaceuticals & Consumer Healthcare in its company registry.
Jamjoom Pharmaceuticals Factory Company manufactures and distributes pharmaceutical and consumer products including human medicines, nutraceuticals, antibiotics, and treatments for various conditions across Saudi Arab...
Cyborg Score thesis
A diversified regional pharmaceutical manufacturer with strong revenue growth, solid profitability, and attractive dividend yield...
Read the full analyst-debate transcript →Get the Latest Jamjoom Pharmaceuticals Factory Company Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeJamjoom Pharmaceuticals Factory Company Overview
Pro stress-test →Jamjoom Pharmaceuticals Factory Company manufactures and distributes pharmaceutical and consumer products including human medicines, nutraceuticals, antibiotics, and treatments for various conditions across Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally. The company supplies products in over 36 countries and operates as a leading player in the pharmaceuticals and consumer healthcare space.
Strategic Profile
Pro stress-test →The company focuses on developing, manufacturing, and distributing generic pharmaceuticals, cosmetics, and consumer healthcare products. Operating through pharmaceutical and consumer health segments with subsidiaries and 8 branches, the company leverages an extensive distribution network across multiple regions.
Competitive Landscape
Pro stress-test →Jamjoom operates in the regional pharmaceutical market alongside other Gulf and Middle Eastern players, competing primarily on manufacturing scale, product portfolio breadth, and distribution reach. The company's focus on generic pharmaceuticals and over-the-counter products gives it competitive positioning in price-sensitive markets across the GCC and North Africa.
Industry Context
Jamjoom Pharmaceuticals Factory Company operates in Pharmaceuticals & Consumer Healthcare.
Key facts
Founded: 1994 · Headquarters: Jeddah, Saudi Arabia · Employees: 1,080 · Revenue: 1.32B SAR (2024) · Market cap: 10.49B SAR